![Harry Raftopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harry Raftopoulos
Corporate Officer/Principal bij
EIKON THERAPEUTICS, INC.
Profiel
Harry Raftopoulos is Senior Vice President & Clinical Research at Eikon Therapeutics, Inc. since 2023.
Formerly, Mr. Raftopoulos was a Scientific Advisor at FutuRx Ltd.
Actieve functies van Harry Raftopoulos
| Bedrijven | Functie | Begin |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2023 |
Eerdere bekende functies van Harry Raftopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Consultant / Adviseur | 01-04-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company that dedicated to inventing and developing of breakthrough therapeutics | Health Technology |
